IDEAYA Biosciences (IDYA) Total Liabilities (2018 - 2026)

IDEAYA Biosciences has disclosed Total Liabilities across 9 years of filings, most recently posting $93.1 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $93.1 million, up 21.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $93.1 million (up 21.66% YoY), and the FY2025 annual result was $86.4 million, up 33.02% from the prior year.
• Total Liabilities came in at $93.1 million for Q1 2026 at IDEAYA Biosciences, up from $86.4 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $93.1 million in Q3 2025 to a low of $24.9 million in Q3 2023.
• The 5-year median for Total Liabilities is $59.5 million (2024), against an average of $56.1 million.
• Across the five-year window, Total Liabilities plunged 62.22% in 2023 and jumped 191.83% in 2025, its largest moves.
• IDEAYA Biosciences' Total Liabilities stood at $38.5 million in 2022, then decreased by 26.71% to $28.2 million in 2023, then surged by 130.09% to $64.9 million in 2024, then jumped by 33.02% to $86.4 million in 2025, then gained by 7.75% to $93.1 million in 2026.
• The last three Total Liabilities figures came in at $93.1 million (Q1 2026), $86.4 million (Q4 2025), and $93.1 million (Q3 2025), per Business Quant data.